Literature DB >> 23262291

miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules.

Raghu Bhushan1, Johannes Grünhagen, Jessica Becker, Peter N Robinson, Claus-Eric Ott, Petra Knaus.   

Abstract

Osteoblastic differentiation is controlled by complex interplay of several signaling pathways and associated key transcription factors, as well as by microRNAs (miRNAs). In our current study, we found miR-181a to be highly upregulated during BMP induced osteoblastic differentiation of C2C12 and MC3T3 cells. Overexpression of miR-181a led to upregulation of key markers of osteoblastic differentiation as well as enhanced ALP levels and Alizarin red staining, indicating the importance of this miRNA for osteoblastic differentiation. Further, we show that miR-181 isoforms (181a, 181b, 181c) are expressed during different stages of mouse calvarial and tibial development, implying their role in both endochondral and intramembranous ossification. We found several direct and indirect targets of miR-181a to be downregulated by global mRNA expression profiling. Our results demonstrate that miR-181a promotes osteoblastic differentiation via repression of TGF-β signaling molecules by targeting the negative regulator of osteoblastic differentiation Tgfbi (Tgf-beta induced) and TβR-I/Alk5 (TGF-β type I receptor). Furthermore, our findings suggest that Rgs4 and Gata6 are direct targets of miR-181a. Taken together, we provide evidence for a crucial functional link between a specific miRNA, miR-181a and osteoblastic differentiation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23262291     DOI: 10.1016/j.biocel.2012.12.008

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  54 in total

1.  LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.

Authors:  Jiaqian Liang; Xin Li; Yirong Li; Jianjun Wei; Garrett Daniels; Xuelin Zhong; Jinhua Wang; Karen Sfanos; Jonathan Melamed; Jun Zhao; Peng Lee
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 2.  Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis.

Authors:  Maša Alečković; Yibin Kang
Journal:  Bonekey Rep       Date:  2015-04-15

Review 3.  MicroRNAs as regulators of bone homeostasis and bone metastasis.

Authors:  Brian Ell; Yibin Kang
Journal:  Bonekey Rep       Date:  2014-07-02

4.  Intensive Care Foundation Gold Medal Award Presentations.

Authors: 
Journal:  J Intensive Care Soc       Date:  2015-03-17

5.  Upregulation of miR-210 promotes differentiation of mesenchymal stem cells (MSCs) into osteoblasts.

Authors:  Ali Asgharzadeh; Shaban Alizadeh; Mohammad Reza Keramati; Masoud Soleimani; Amir Atashi; Mahdi Edalati; Zahra Kashani Khatib; Mohammad Rafiee; Mohyedin Barzegar; Hengamehsadat Razavi
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

Review 6.  MicroRNAs in bone diseases.

Authors:  L Gennari; S Bianciardi; D Merlotti
Journal:  Osteoporos Int       Date:  2016-11-30       Impact factor: 4.507

Review 7.  Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.

Authors:  Mohammed Alqinyah; Shelley B Hooks
Journal:  Cell Signal       Date:  2017-10-16       Impact factor: 4.315

Review 8.  Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Authors:  Kalyani C Patil; Carolina Soekmadji
Journal:  Subcell Biochem       Date:  2021

Review 9.  MicroRNAs involved in bone formation.

Authors:  Garyfallia Papaioannou; Fatemeh Mirzamohammadi; Tatsuya Kobayashi
Journal:  Cell Mol Life Sci       Date:  2014-08-10       Impact factor: 9.261

10.  microRNAs and connexins in bone: interaction and mechanisms of delivery.

Authors:  Lilian I Plotkin; Rafael Pacheco-Costa; Hannah M Davis
Journal:  Curr Mol Biol Rep       Date:  2017-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.